Mitofusin-2 Ameliorates High-fat Diet-induced Insulin Resistance in Liver of Rats

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2013 Mar 30

PMID 23538485

Citations 30

Authors

Ke-Xin Gan

Chao Wang

Jin-Hu Chen

Chun-Jing Zhu

Guang-Yao Song

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the effects of mitofusin-2 (MFN2) on insulin sensitivity and its potential targets in the liver of rats fed with a high-fat diet (HFD).

Methods: Rats were fed with a control or HFD for 4 or 8 wk, and were then infected with a control or an MFN2 expressing adenovirus once a week for 3 wk starting from the 9(th) wk. Blood glucose (BG), plasma insulin and insulin sensitivity of rats were determined at end of the 4(th) and 8(th) wk, and after treatment with different amounts of MFN2 expressing adenovirus (10(8), 10(9) or 10(10) vp/kg body weight). BG levels were measured by Accu-chek Active Meter. Plasma insulin levels were analyzed by using a Rat insulin enzyme-linked immunosorbent assay kit. Insulin resistance was evaluated by measuring the glucose infusion rate (GIR) using a hyperinsulinemic euglycemic clamp technique. The expression or phosphorylation levels of MFN2 and essential molecules in the insulin signaling pathway, such as insulin receptor (INSR), insulin receptor substrate 2 (IRS2), phosphoinositide-3-kinase (PI3K), protein kinase beta (AKT2) and glucose transporter type 2 (GLUT2) was assayed by quantitative real-time polymerase chain reaction and Western-blotting.

Results: After the end of 8 wk, the body weight of rats receiving the normal control diet (ND) and the HFD was not significantly different (P > 0.05). Compared with the ND group, GIR in the HFD group was significantly decreased (P < 0.01), while the levels of BG, triglycerides (TG), total cholesterol (TC) and insulin in the HFD group were significantly higher than those in the ND group (P < 0.05). Expression of MFN2 mRNA and protein in liver of rats was significantly down-regulated in the HFD group (P < 0.01) after 8 wk of HFD feeding. The expression of INSR, IRS2 and GLUT2 were down-regulated markedly (P < 0.01). Although there were no changes in PI3K-P85 and AKT2 expression, their phosphorylation levels were decreased significantly (P < 0.01). After intervention with MFN2 expressing adenovirus for 3 wk, the expression of MFN2 mRNA and protein levels were up-regulated (P < 0.01). There was no difference in body weight of rats between the groups. The levels of BG, TG, TC and insulin in rats were lower than those in the Ad group (P < 0.05), but GIR in rats infected with Ad-MFN2 was significantly increased (P < 0.01), compared with the Ad group. The expression of INSR, IRS2 and GLUT2 was increased, while phosphorylation levels of PI3K-P85 and AKT2 were increased (P < 0.01), compared with the Ad group.

Conclusion: HFDs induce insulin resistance, and this can be reversed by MFN2 over-expression targeting the insulin signaling pathway.

Citing Articles

Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies.

Meng X, Zhang H, Zhao Z, Li S, Zhang X, Guo R Mol Med. 2025; 31(1):61.

PMID: 39966707 PMC: 11834690. DOI: 10.1186/s10020-025-01101-z.

High-fat diet causes mitochondrial damage and downregulation of mitofusin-2 and optic atrophy-1 in multiple organs.

Zheng P, Ma W, Gu Y, Wu H, Bian Z, Liu N J Clin Biochem Nutr. 2023; 73(1):61-76.

PMID: 37534099 PMC: 10390808. DOI: 10.3164/jcbn.22-73.

Mitofusin-2 gene polymorphisms and metabolic dysfunction associated fatty liver disease: a case-control study in a Chinese population.

Yuan X, Hou M, Wang Y, Zhang S, Li L, Mi Y J Int Med Res. 2023; 51(7):3000605231187953.

PMID: 37522325 PMC: 10392247. DOI: 10.1177/03000605231187953.

Using mass spectrometry imaging to visualize age-related subcellular disruption.

Hogan K, Zeidler J, Beasley H, Alsaadi A, Alshaheeb A, Chang Y Front Mol Biosci. 2023; 10:906606.

PMID: 36968274 PMC: 10032471. DOI: 10.3389/fmolb.2023.906606.

Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl-CoA.

Ngo J, Choi D, Stanley I, Stiles L, Molina A, Chen P EMBO J. 2023; 42(11):e111901.

PMID: 36917141 PMC: 10233380. DOI: 10.15252/embj.2022111901.

References

Calegari V, Alves M, Picardi P, Inoue R, Franchini K, Saad M . Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems. Endocrinology. 2004; 146(2):579-88. DOI: 10.1210/en.2004-0466. View

Liesa M, Palacin M, Zorzano A . Mitochondrial dynamics in mammalian health and disease. Physiol Rev. 2009; 89(3):799-845. DOI: 10.1152/physrev.00030.2008. View

Emanuelli B, Peraldi P, Filloux C, Hilton D, Van Obberghen E . SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem. 2000; 275(21):15985-91. DOI: 10.1074/jbc.275.21.15985. View

da Silva A, Kuo J, Tallam L, Hall J . Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension. 2004; 43(2):383-7. DOI: 10.1161/01.HYP.0000111139.94378.74. View

Kerouz N, Horsch D, Pons S, Kahn C . Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest. 1998; 100(12):3164-72. PMC: 508530. DOI: 10.1172/JCI119872. View

Westermann B . Molecular machinery of mitochondrial fusion and fission. J Biol Chem. 2008; 283(20):13501-5. DOI: 10.1074/jbc.R800011200. View

Santel A, Fuller M . Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 2001; 114(Pt 5):867-74. DOI: 10.1242/jcs.114.5.867. View

Sebastian D, Hernandez-Alvarez M, Segales J, Sorianello E, Munoz J, Sala D . Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci U S A. 2012; 109(14):5523-8. PMC: 3325712. DOI: 10.1073/pnas.1108220109. View

Gastaldi G, Russell A, Golay A, Giacobino J, Habicht F, Barthassat V . Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia. 2007; 50(11):2348-55. DOI: 10.1007/s00125-007-0782-1. View

10.

Coletta D, Mandarino L . Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria. Am J Physiol Endocrinol Metab. 2011; 301(5):E749-55. PMC: 3214002. DOI: 10.1152/ajpendo.00363.2011. View

11.

Rui L, Yuan M, Frantz D, Shoelson S, White M . SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem. 2002; 277(44):42394-8. DOI: 10.1074/jbc.C200444200. View

12.

Eckel R, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2005; 365(9468):1415-28. DOI: 10.1016/S0140-6736(05)66378-7. View

13.

Leturque A, Brot-Laroche E, Le Gall M . GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab. 2009; 296(5):E985-92. DOI: 10.1152/ajpendo.00004.2009. View

14.

Zhang R, Han M, Zheng B, Li Y, Shu Y, Wen J . Krüppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs. Acta Pharmacol Sin. 2010; 31(10):1293-302. PMC: 4012908. DOI: 10.1038/aps.2010.96. View

15.

Chen X, Xu Y . Liver-specific reduction of Mfn2 protein by RNAi results in impaired glycometabolism and lipid homeostasis in BALB/c mice. J Huazhong Univ Sci Technolog Med Sci. 2009; 29(6):689-96. DOI: 10.1007/s11596-009-0603-5. View

16.

Chen H, Chomyn A, Chan D . Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005; 280(28):26185-92. DOI: 10.1074/jbc.M503062200. View

17.

Saltiel A, Kahn C . Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001; 414(6865):799-806. DOI: 10.1038/414799a. View

18.

White M . The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem. 1998; 182(1-2):3-11. View

19.

Buettner R, Parhofer K, Woenckhaus M, Wrede C, Kunz-Schughart L, Scholmerich J . Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol. 2006; 36(3):485-501. DOI: 10.1677/jme.1.01909. View

20.

Ueki K, Kondo T, Tseng Y, Kahn C . Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A. 2004; 101(28):10422-7. PMC: 478587. DOI: 10.1073/pnas.0402511101. View